FOURTH AMENDMENT TO LEASE AGREEMENTLease Agreement • March 10th, 2020 • Krystal Biotech, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 10th, 2020 Company IndustryTHIS FOURTH AMENDMENT TO LEASE AGREEMENT (the “Fourth Amendment”) is made as of the 22nd day of October, 2018, by and between Wharton Lender Associates, L.P., (“Landlord”), and Krystal Biotech Inc., (“Tenant”).
FIFTH AMENDMENT TO LEASE AGREEMENTLease Agreement • March 10th, 2020 • Krystal Biotech, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 10th, 2020 Company IndustryTHIS FIFTH AMENDMENT TO LEASE AGREEMENT (the "Fifth Amendment") is made as of the 10th day of December, 2018, by and between Wharton Lender Associates, L.P., a Pennsylvania limited partnership ("Landlord"), and Krystal Biotech Inc. a Delaware corporation formerly known as Krystal Biotech, LLC, a California limited liability company, ('"Tenant").
THIRD AMENDMENT TO LEASE AGREEMENTLease Agreement • March 10th, 2020 • Krystal Biotech, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 10th, 2020 Company IndustryTHIS THIRD AMENDMENT TO LEASE AGREEMENT (the “Third Amendment”) is made as of the 31st day of May, 2018, by and between Wharton Lender Associates, L.P., (“Landlord”), and Krystal Biotech Inc. (“Tenant”).